Results     04-Jun-19
Announcements
Orchid Pharma reports standalone net loss of Rs 13.45 crore in the March 2019 quarter
Sales rise 4.03% to Rs 162.07 crore
Net Loss of Orchid Pharma reported to Rs 13.45 crore in the quarter ended March 2019 as against net loss of Rs 92.37 crore during the previous quarter ended March 2018. Sales rose 4.03% to Rs 162.07 crore in the quarter ended March 2019 as against Rs 155.79 crore during the previous quarter ended March 2018.

For the full year,net loss reported to Rs 101.05 crore in the year ended March 2019 as against net loss of Rs 355.28 crore during the previous year ended March 2018. Sales declined 9.40% to Rs 583.65 crore in the year ended March 2019 as against Rs 644.17 crore during the previous year ended March 2018.

ParticularsQuarter EndedYear Ended
 Mar. 2019Mar. 2018% Var.Mar. 2019Mar. 2018% Var.
Sales162.07155.79 4 583.65644.17 -9
OPM %-4.764.99 --2.172.11 -
PBDT-3.23-69.95 95 3.93-268.18 LP
PBT-34.57-102.52 66 -125.99-401.47 69
NP-13.45-92.37 85 -101.05-355.28 72

Previous News
  Sensex up 273 pts; IT shares outperforms
 ( Market Commentary - Mid-Session 06-Jun-24   14:42 )
  Orchid Pharma consolidated net profit rises 287.75% in the December 2023 quarter
 ( Results - Announcements 08-Feb-24   17:29 )
  Orchid Pharma jumps after receiving USFDA nod for Exblifep injections
 ( Hot Pursuit - 23-Feb-24   16:18 )
  Orchid Pharma gains on DCGI nod for new antibiotic drug combination
 ( Hot Pursuit - 06-Jun-24   12:38 )
  Orchid Pharma AGM scheduled
 ( Corporate News - 10-Jul-23   10:06 )
  Orchid Pharma to convene EGM
 ( Corporate News - 05-Dec-22   09:39 )
  Orchid Pharma reports standalone net loss of Rs 13.45 crore in the March 2019 quarter
 ( Results - Announcements 04-Jun-19   17:13 )
  Orchid Pharma and Orchid Bio Pharma signs MoU to obtain license for 7ACA technology
 ( Corporate News - 04-Mar-23   10:20 )
  Orchid Pharma incorporates wholly owned subsidiary 'Orchid Bio-Pharma'
 ( Corporate News - 25-Mar-22   13:51 )
  Orchid Pharma receives DCGI approval for Enmetazobactam
 ( Corporate News - 06-Jun-24   13:06 )
  Orchid Pharma to hold board meeting
 ( Corporate News - 17-May-21   10:15 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top